Daily Cannabis Industry Intelligence
Curated from social media posts and threads
Published: Saturday, May 2, 2026 | 7:00 AM ET | Curated by Sheeba
Curaleaf Completes Full Acquisition of Four 20 Pharma
Curaleaf Holdings (TSX: CURA) completed its buyout of the remaining 45% stake in Four 20 Pharma, a leading EU-GMP licensed German medical cannabis producer. The deal strengthens Curaleaf’s vertically integrated supply chain. Read more →
Vireo Growth Acquires FLUENT in Florida Consolidation Deal
Vireo Growth (CNSX: VREO) entered a definitive agreement to acquire Florida-based FLUENT Corp. in an all-stock transaction. Combined entity will operate ~74 retail stores and 144,000 sq ft cultivation. Q4 2026 close. Read more →
Trulieve Files DEA Schedule III Medical Registration
Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF) filed DEA applications for Schedule III registration of 200+ medical dispensaries. Under expedited pathway, licensure deemed approved unless DEA objects within 60 days. Read more →
Verano Holdings Reports Strong Q1 2026 Revenue
Verano Holdings announced robust first-quarter 2026 results with $208M revenue, continuing growth trajectory as leading multi-state operator. Read more →
Aurora Cannabis Acquires Safari Flower Company
Aurora Cannabis (NASDAQ: ACB, TSX: ACB) acquired Safari Flower’s 59,000 sq ft EU-GMP facility in Ontario for $26.5M. Expansion supports Germany, Australia, Poland, UK markets. Read more →
DEA Schedule III Registration Creates Compliance Catch-22
Industry attorneys flag critical issue: DEA forms require operators to acknowledge activity resembling federal trafficking. Experts pressing for form revisions before deadline—potential barrier to compliance. Read more →
Cannabis-Derived Pharma Companies Revive IPO Plans
Pharmaceutical companies developing cannabis therapeutics reviving IPO plans post-rescheduling. Bankers anticipate uptick in cannabis-pharma deal flow as barriers lower, reshaping valuations. Read more →
Splash-Medterra CBD Merger Agreement
Splash Beverage Group (NYSE: SBEV) executed non-binding LOI with Medterra CBD. Combined entity as cannabinoid wellness platform serving 2M+ customers, pursuing CMS CBD pilot reimbursement. Read more →
Fette Pharma Exits Restructuring
Fette Pharma, German medical cannabis distributor, formally exited restructuring. Move clears regulatory overhangs, positions for accelerated competition in Europe’s largest medical market. Read more →
Cannabis ETFs Return to Institutional Radars
Cannabis-focused ETFs back on institutional radars with positive flows post-rescheduling. Asset remains volatile but liquidity and engagement clearly returning. Read more →
Conflicting Federal Guidance Muddles Benefits
Week post-rescheduling, conflicting federal signals cloud operator clarity on banking, taxation, interstate movement. Disorderly rollout risks blunting commercial upside priced into Schedule III decision. Read more →
M&A Wave Accelerates: European Consolidation Leads
Industry consolidation accelerates globally with European medical cannabis transactions leading. Organigram’s Sanity Group acquisition signals operators moving now to capture market advantages. Read more →
About Village Green: Curated daily cannabis industry intelligence. Sourced from Twitter/X, Reddit, LinkedIn, industry publications.
Next update: Sunday, May 3, 2026 | 7:00 AM ET